Diagnostic accuracy of combinatorial mRNA biomarkers for non-invasive detection and therapy monitoring of oral and oropharyngeal SCC

This study presents a promising non-invasive biomarker panel for oral and oropharyngeal SCC detection. Further validation in larger cohorts is needed to confirm diagnostic value and clarify sex specificity. The approach is adaptable to other tumour types and sample materials, supporting molecular diagnostics. The workflow shows all project steps from sampling to marker localisation in FFPE tissue. In the discovery phase, RNA sequencing was used to find potential mRNA markers in swab samples. Via strict filtering, markers for RT-qPCR were selected and verified in a bigger cohort in the validation phase. Selected markers were then used to do combinatorial analysis to improve the specificity and sensitivity compared to that of the single markers. Finally, markers were verified and localised in primary oral and oropharyngeal SCC FFPE tissue. Created with BioRender.com.

Authors

Institutions

Publication Details

Journal
British Journal of Cancer
Published
2026-01-08
DOI
https://doi.org/10.1038/s41416-025-03313-w
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diagnostic accuracy of combinatorial mRNA biomarkers for non-invasive detection and therapy monitoring of oral and oropharyngeal SCC

U. Hamberger, R. Kim, Bart Verwaaijen, Leonie Hose et al.
British Journal of Cancer
Head and Neck Cancer Studies
article

Diagnostic accuracy of combinatorial mRNA biomarkers for non-invasive detection and therapy monitoring of oral and oropharyngeal SCC

U. Hamberger, R. Kim, Bart Verwaaijen, Leonie Hose, T. Busche, Peter Goon, Ingo Todt, Matthias Schürmann, Lars-Uwe Scholtz, Christian Rückert-Reed, Frank Brasch, Alina Celine Tekin
article en

Abstract

This study presents a promising non-invasive biomarker panel for oral and oropharyngeal SCC detection. Further validation in larger cohorts is needed to confirm diagnostic value and clarify sex specificity. The approach is adaptable to other tumour types and sample materials, supporting molecular diagnostics. The workflow shows all project steps from sampling to marker localisation in FFPE tissue. In the discovery phase, RNA sequencing was used to find potential mRNA markers in swab samples. Via strict filtering, markers for RT-qPCR were selected and verified in a bigger cohort in the validation phase. Selected markers were then used to do combinatorial analysis to improve the specificity and sensitivity compared to that of the single markers. Finally, markers were verified and localised in primary oral and oropharyngeal SCC FFPE tissue. Created with BioRender.com.

British Journal of CancerVol. 134(6)
National University of Singapore (SG), Bielefeld University (DE), Klinikum Bielefeld (DE), National University Health System (SG)
Universität Bielefeld
No poverty
Openalex Percentile: Top 93%
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Diagnostic accuracy of combinatorial mRNA biomarkers for non-invasive detection and therapy monitoring of oral and oropharyngeal SCC — U. Hamberger, R. Kim, et al. · British Journal of Cancer (2026) | TGRS Research Map | TGRS